197 related articles for article (PubMed ID: 30414351)
1. Shigella effector IpaH4.5 targets 19S regulatory particle subunit RPN13 in the 26S proteasome to dampen cytotoxic T lymphocyte activation.
Otsubo R; Mimuro H; Ashida H; Hamazaki J; Murata S; Sasakawa C
Cell Microbiol; 2019 Mar; 21(3):e12974. PubMed ID: 30414351
[TBL] [Abstract][Full Text] [Related]
2. Shigella flexneri T3SS effector IpaH4.5 modulates the host inflammatory response via interaction with NF-κB p65 protein.
Wang F; Jiang Z; Li Y; He X; Zhao J; Yang X; Zhu L; Yin Z; Li X; Wang X; Liu W; Shang W; Yang Z; Wang S; Zhen Q; Zhang Z; Yu Y; Zhong H; Ye Q; Huang L; Yuan J
Cell Microbiol; 2013 Mar; 15(3):474-85. PubMed ID: 23083102
[TBL] [Abstract][Full Text] [Related]
3. Shigella IpaH Family Effectors as a Versatile Model for Studying Pathogenic Bacteria.
Ashida H; Sasakawa C
Front Cell Infect Microbiol; 2015; 5():100. PubMed ID: 26779450
[TBL] [Abstract][Full Text] [Related]
4. Bacterial E3 Ubiquitin Ligase IpaH4.5 of Shigella flexneri Targets TBK1 To Dampen the Host Antibacterial Response.
Zheng Z; Wei C; Guan K; Yuan Y; Zhang Y; Ma S; Cao Y; Wang F; Zhong H; He X
J Immunol; 2016 Feb; 196(3):1199-208. PubMed ID: 26700764
[TBL] [Abstract][Full Text] [Related]
5. Ubiquitination and degradation of GBPs by a Shigella effector to suppress host defence.
Li P; Jiang W; Yu Q; Liu W; Zhou P; Li J; Xu J; Xu B; Wang F; Shao F
Nature; 2017 Nov; 551(7680):378-383. PubMed ID: 29144452
[TBL] [Abstract][Full Text] [Related]
6. Shigella IpaH7.8 E3 ubiquitin ligase targets glomulin and activates inflammasomes to demolish macrophages.
Suzuki S; Mimuro H; Kim M; Ogawa M; Ashida H; Toyotome T; Franchi L; Suzuki M; Sanada T; Suzuki T; Tsutsui H; Núñez G; Sasakawa C
Proc Natl Acad Sci U S A; 2014 Oct; 111(40):E4254-63. PubMed ID: 25246571
[TBL] [Abstract][Full Text] [Related]
7. New insights into the crosstalk between Shigella and T lymphocytes.
Salgado-Pabón W; Konradt C; Sansonetti PJ; Phalipon A
Trends Microbiol; 2014 Apr; 22(4):192-8. PubMed ID: 24613405
[TBL] [Abstract][Full Text] [Related]
8.
Sun J; Wang X; Lin H; Wan L; Chen J; Yang X; Li D; Zhang Y; He X; Wang B; Dong M; Zhong H; Wei C
J Med Microbiol; 2021 Jul; 70(7):. PubMed ID: 34296983
[No Abstract] [Full Text] [Related]
9. The Shigella OspC3 effector inhibits caspase-4, antagonizes inflammatory cell death, and promotes epithelial infection.
Kobayashi T; Ogawa M; Sanada T; Mimuro H; Kim M; Ashida H; Akakura R; Yoshida M; Kawalec M; Reichhart JM; Mizushima T; Sasakawa C
Cell Host Microbe; 2013 May; 13(5):570-583. PubMed ID: 23684308
[TBL] [Abstract][Full Text] [Related]
10. ShiA abrogates the innate T-cell response to Shigella flexneri infection.
Ingersoll MA; Zychlinsky A
Infect Immun; 2006 Apr; 74(4):2317-27. PubMed ID: 16552062
[TBL] [Abstract][Full Text] [Related]
11. Antigen-specific CD8(+) T cells fail to respond to Shigella flexneri.
Jehl SP; Doling AM; Giddings KS; Phalipon A; Sansonetti PJ; Goldberg MB; Starnbach MN
Infect Immun; 2011 May; 79(5):2021-30. PubMed ID: 21357720
[TBL] [Abstract][Full Text] [Related]
12.
Schnupf P; Sansonetti PJ
Microbiol Spectr; 2019 Mar; 7(2):. PubMed ID: 30953429
[No Abstract] [Full Text] [Related]
13. B lymphocytes undergo TLR2-dependent apoptosis upon Shigella infection.
Nothelfer K; Arena ET; Pinaud L; Neunlist M; Mozeleski B; Belotserkovsky I; Parsot C; Dinadayala P; Burger-Kentischer A; Raqib R; Sansonetti PJ; Phalipon A
J Exp Med; 2014 Jun; 211(6):1215-29. PubMed ID: 24863068
[TBL] [Abstract][Full Text] [Related]
14. Shigella IpaH0722 E3 ubiquitin ligase effector targets TRAF2 to inhibit PKC-NF-κB activity in invaded epithelial cells.
Ashida H; Nakano H; Sasakawa C
PLoS Pathog; 2013; 9(6):e1003409. PubMed ID: 23754945
[TBL] [Abstract][Full Text] [Related]
15. Molecular and Cellular Mechanisms of Shigella flexneri Dissemination.
Agaisse H
Front Cell Infect Microbiol; 2016; 6():29. PubMed ID: 27014639
[TBL] [Abstract][Full Text] [Related]
16. Type III secretion effectors of the IpaH family are E3 ubiquitin ligases.
Rohde JR; Breitkreutz A; Chenal A; Sansonetti PJ; Parsot C
Cell Host Microbe; 2007 Mar; 1(1):77-83. PubMed ID: 18005683
[TBL] [Abstract][Full Text] [Related]
17. Injection of T3SS effectors not resulting in invasion is the main targeting mechanism of
Pinaud L; Samassa F; Porat Z; Ferrari ML; Belotserkovsky I; Parsot C; Sansonetti PJ; Campbell-Valois FX; Phalipon A
Proc Natl Acad Sci U S A; 2017 Sep; 114(37):9954-9959. PubMed ID: 28847968
[TBL] [Abstract][Full Text] [Related]
18. The Shigella flexneri effector OspI deamidates UBC13 to dampen the inflammatory response.
Sanada T; Kim M; Mimuro H; Suzuki M; Ogawa M; Oyama A; Ashida H; Kobayashi T; Koyama T; Nagai S; Shibata Y; Gohda J; Inoue J; Mizushima T; Sasakawa C
Nature; 2012 Mar; 483(7391):623-6. PubMed ID: 22407319
[TBL] [Abstract][Full Text] [Related]
19. The roles of the virulence factor IpaB in Shigella spp. in the escape from immune cells and invasion of epithelial cells.
Yang SC; Hung CF; Aljuffali IA; Fang JY
Microbiol Res; 2015 Dec; 181():43-51. PubMed ID: 26640051
[TBL] [Abstract][Full Text] [Related]
20. Pathogenic ubiquitination of GSDMB inhibits NK cell bactericidal functions.
Hansen JM; de Jong MF; Wu Q; Zhang LS; Heisler DB; Alto LT; Alto NM
Cell; 2021 Jun; 184(12):3178-3191.e18. PubMed ID: 34022140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
